Round two for liver gene therapy
- 1 March 1996
- journal article
- Published by Springer Nature in Nature Genetics
- Vol. 12 (3), 232-233
- https://doi.org/10.1038/ng0396-232
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type INature Genetics, 1996
- A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemiaNature Medicine, 1995
- Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type INature Genetics, 1995
- Self-induced correction of the genetic defect in tyrosinemia type I.JCI Insight, 1994
- Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemiaNature Genetics, 1994
- Replacement of Diseased Mouse Liver by Hepatic Cell TransplantationScience, 1994
- Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice.Genes & Development, 1993
- Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect.JCI Insight, 1993
- Long-Term Improvement of Hypercholesterolemia After Ex Vivo Gene Therapy in LDLR-Deficient RabbitsScience, 1991
- Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgeneCell, 1991